Does Aortic Valve Replacement Restore Normal Life Expectancy: a Twenty-Year Relative Survival Study

Alexander Manché, Liberato Camilleri, Dorothy Gauci

Abstract


Background This 20-year relative survival study investigates life expectancy in defined age cohorts and evaluates the role of patient, procedural and peri-operative variables on absolute survival after aortic valve replacement.

 

Methods Absolute long-term survival variance was calculated using Cox regression analysis in 585 consecutive aortic valve replacement patients. Relative survival curves in defined age groups were constructed using age- and gender-matched controls.

Results There were 12 peri-operative deaths (2.1%), and 11 further deaths (1.9%) during the first year. 154 patients (26.3%) died subsequently and 408 patients (69.7%) were alive after 20 years. Relative survival increased with age: in patients over 68 survival was equivalent to an age- and gender-matched population. Patient risk indicators for decreased absolute survival included age, Parsonnet score, additive and logistic EuroSCORE, and for increased absolute survival included weight, body surface area, and stroke volume. Procedural risk indicators for decreased absolute survival included bypass time, use of a tissue valve, and prosthesis-patient mismatch with size 19 valves, and for an increased absolute survival included use of a mechanical valve. Post-operative risk indicators for decreased absolute survival included ITU stay, ventilation time, transfusion, haemorrhage volume and new-onset atrial fibrillation/flutter. Strong risk indicators included intra-aortic balloon pump use, and dialysis.

 

Conclusions Patients over 68 years discharged from hospital after aortic valve replacement had a similar 10-year survival as an age- and gender-matched population. In this age cohort surgery restored the patient’s normal life expectancy.

 

Key words: aortic valve replacement; absolute survival predictors; relative survival


Full Text:

PDF

References


Gillam LD, Marcoff L, Shames S. Timing of surgery in valvular heart disease: prophylactic surgery vs watchful waiting in the asymptomatic patient. Can J Cardiol 2014;30:1035-1045. http://dx.doi.org/10.1016/j.cjca.2014.06.019

Hirshfeld JW, Epstein SE, Roberts AJ, Glancy DL, Morrow AG. Indices predicting long-term survival after valve replacement in patients with aortic regurgitation and patients with aortic stenosis. Circulation 1974;50:1190-1199. http://dx.doi.org/10.1161/01.CIR.50.6.1190

Brock RC. The present position of cardiac surgery. Bradshaw lecture delivered at the Royal College of Surgeons of England on 11th December 1957. Ann R Coll Surg Engl 1958;23:213-237. DOI: 13583920

Horstkotte D, Loogen F. The natural history of aortic stenosis. Eur Heart J 1988;9(suppl E):57-64. http://dx.doi.org/10.1093/eurheartj/9.suppl_E.57

Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation 1999;99:1851-1857. http://dx.doi.org/10.1161/01.CIR.99.14.1851

Hancock EW. Timing of valve replacement in aortic stenosis. Circulation 1990;82:310-312. http://dx.doi.org/10.1161/01.CIR.82.1.310

Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-1011. http://dx.doi.org/10.1016/S0140-6736(06)69208-8

Pohar M, Stare J. Relative survival analysis in R. Comput Meth Progr Biomed 2006;81:272-278. http://dx.doi.org/10.1016/j.cmpb.2006.01.004

Rosenheck VT, Lung B, Tornos P, Antunes MJ, Prendergast BD, Otto CM, et al. ESC working group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J 2012;33:822-828. http://dx.doi.org/10.1093/eurheartj/ehr061

Lassnigg A, Hiesmayr M, Frantal S, Brannath W, Mouhieddine M, Presteri E, et al. Long-term absolute and relative survival after aortic valve replacement: a prospective cohort study. Eur J Anaesthesiol 2013;30:695-703. http://dx.doi.org/10.1097/EJA.0b013e3283657829

Ewbank DC, Gomez De Leon JC, Stoto MA. A reducible four-parameter system of model life tables. Population Studies 1983; 37:105-127. http://dx.doi.org/10.1080/00324728.1983.10405927

Ettema RGA, Peelen LM, Kalkman CJ, Nierich AP, Moons KGM, Schuurmans MJ. Predicting prolonged intensive care unit stays in older cardiac surgery patients: a validation study. Intensive Care Med 2011;37:1480-1487. http://dx.doi.org/10.1007/s00134-011-2314-1

Chaliki HP, Mohty D, Avierinos JF, Scott CG, Schaff HV, Tajik AJ, et al. Outcomes after aortic valve replacement in patients with severe aortic regurgitation and markedly reduced left ventricular function. Circulation 2002;106:2687-2693. http://dx.doi.org/10.1161/01.CIR.0000038498.59829.38

Pibarot P, Dumesnil JG. Patient-prosthesis mismatch : definition, clinical impact, and prevention. Heart 2006;92:1022-1029. http://dx.doi.org/10.1136/hrt.2005.067363

Mosquera VX, Bouzas-Mosquera A, Bautista-Hernandez V, Estévez-Cid F, Herrera-Noreña JM, Alvarez-García N, et al. The CarboMedics supra-annular Top Hat valve improves long-term left ventricular mass regression. doi:10.1016/j.jtcvs.2014.06.082

Head SJ, Mokhles MM, Osnabrugge RLJ, Pibarot P, Mack MJ, Takkenberg JJM, et al. The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27,186 patients with 133,141 patient-years. Eur Heart J 2012;33:1518-1529. http://dx.doi.org/10.1093/eurheartj/ehs003

Kukucka M, Pasic M, Dreysse S, Buz S, Drews T, Mladenow A, et al. Patient-prosthesis mismatch after transapical aortic valve implantation. Ann Cardiothorac Surg 2012;1:172-175. http://dx.doi.org/10.3978/j.issn.2225-319X.2012.07.05

Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002;74:1180-1186. http://dx.doi.org/10.1016/S0003-4975(02)03766-9

Surgenor SD, Kramer RS, Olmstead EM, Ross CS, Sellke FW, Likosky DS, et al. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 2009;108:1741-1746. http://dx.doi.org/10.1213/ane.0b013e3181a2a696

Filardo G, Hamilton C, Hamman B, Hebeler RF, Adams J, Grayburn P. New-onset postoperative atrial fibrillation and long-term survival after aortic valve replacement surgery. Ann Thorac Surg 2010;90:474-479. http://dx.doi.org/10.1016/j.athoracsur.2010.02.081

Fighali SF, Avendano A, Elayda MA, Lee VV, Hernandez C, Siero V, et al. Early and late mortality of patients undergoing aortic valve replacement after previous coronary artery bypass graft surgery. Circulation 1995;92:163-168. http://dx.doi.org/10.1161/01.CIR.92.9.163

Rosenhek R, Maurer G, Baumgartner H. Should early elective surgery be performed in patients with severe but asymptopmatic aortic stenosis? Eurpoean Heart Journal 2002;23:1417-1421. http://dx.doi.org/10.1053/euhj.2002.3163

Otto MO, Burwash IG, Legget ME, Munt BI, Fujioka M, Healy NL, et al. Prospective study of asymptomatic aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997;95:2262-2270. http://dx.doi.org/10.1161/01.CIR.95.9.2262

Carabello BA. Timing of valve replacement in aortic stenosis. Circulation 1997;95:2241-2243. http://dx.doi.org/10.1007/978-94-011-3820-8_3

Brown ML, Pellikka PA, Schaff HV, Scott CG, Mullany CJ, Sundt TM, et al. The benefits of early valve replacement in asymptomatic patients with severe aortic stenosis. J Thorac Cardiovasc Surg 2008;135:308-315. http://dx.doi.org/10.1016/j.jtcvs.2007.08.058

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2. http://dx.doi.org/10.17987/icfj.v2i1.4




DOI: https://doi.org/10.17987/icfj.v6i0.138

Comments on this article

View all comments


Copyright (c) 2016 Alexander Manché

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.